Previous Page  5 / 18 Next Page
Information
Show Menu
Previous Page 5 / 18 Next Page
Page Background

Page 45

conferenceseries

.com

Volume 6

Journal of Infectious Diseases and Therapy

ISSN: 2332-0877

Infection Congress 2018

March 01-02, 2018

March 01-02, 2018 Berlin, Germany

5

th

International Congress on

INFECTIOUS DISEASES

Consequences of

H. pylori

infection and its VacAcytotoxin on mitochondria and mitochondrial DNA:

Impact on gastric pathogenesis

Eliette Touati

Institut Pasteur, France

Statement of the Problem

: Mitochondria alterations and mitochondrial DNA (mtDNA) instabilities are a hallmark of cancer.

Mitochondria represent strategic targets for pathogens also including

Helicobacter pylori.

This bacterium is a major risk factor

for gastric cancer. Up to now, the cytotoxin VacA is the only one

H. pylori

factor known to target and damage mitochondria.

Methodology &Theoretical Orientation

: By in vitro infection of gastric epithelial cells with wild-type and VacA-deficient

H.

pylori

strains, treatment of cells with purified VacA proteins and infection of a mouse model, we show that

H. pylori

deregulates

mitochondria by two novel mechanisms, both rather associated with host cell survival. First, early upon infection VacA induces

transient increase of mitochondrial translocases and a dramatic accumulation of the mitochondrial DNA replication and

maintenance factors POLG and TFAM. These events occur when VacA is not detected intracellularly, therefore do not require

the direct interaction of the cytotoxin with the organelle. They occur independently of the VacA vacuolating activity. In vivo,

these alterations coincide with the evolution of gastric lesions towards severity, concomitantly with the induction of mtDNA

mutations and depletion of mtDNA content. Second, H. pylorus also induces VacA-independent alteration of mitochondrial

replication and import components, suggesting the involvement of additional

H. pylori

activities in mitochondria-mediated

effects.

Conclusions & Significance

: Our findings reveal a novel and early inducer effect of

H. pylori

infection on mitochondrial

translocases and themtDNA replication/transcriptionmachinery components POLG and TFAM. Moreover, we show that VacA

does not account for all consequences of

H. pylori

infection at mitochondria, pointing to the involvement of other bacterial

activities, yet to be determined. These effects of

H. pylori

infection are also relevant in vivo, suggesting that mitochondrial

alterations impact H. pylori-induced gastric inflammation and pathogenicity.

Recent Publications

1. Chatre L, Fernandes J, Michel V, et al (2017)

Helicobacter pylori

targets mitochondrial import and components of

mitochondrial DNA replication machinery through an alternative VacA-dependent and a VacA-independent

mechanisms. Scientific Reports 7: 15901.

2. Majlessi L, Fadel Sayes F, Bureau JF, et al (2017) Colonization with

Helicobacter

is concomitant with modified gut

microbiota and drastic failure of the immune control of

Mycobacterium tuberculosis

. Mucosal Immunology 10:1178-

1189.

3. Matak P, Heinis M, Mathieu J, et al (2015) Myeloid HIF-1 is protective in

H. pylori

mediated gastritis. J of Immunology

194:3259-3266.

4. Fernandes J, Michel V, Carmolinga-Ponce M, et al (2014) Circulating mitochondrial DNA level as a potential non-

invasive biomarker to the early detection of gastric cancer. Cancer Epidemiology, Biomarkers and Prevention 23:2430-

2438.

5. Correia M, Casal S, Vinagre J, Seruca R, Figueiredo C, Touati E and Machado J C (2014)

H. pylori

cholesterol uptake

impacts resistance to docosahexaenoic acid. Int. J of Medical Microbiology, 304: 314-320

Biography

Eliette Touati is currently working as a Senior Researcher at the Institut Pasteur in Paris. Her present work is dedicated to the study of the relationships between

H. pylori

infection and gastric cancer, focusing on the regulation of the host DNA damage and repair response. She works on translational projects to characterize

gastric cancer biomarkers with the goal to develop non-invasive tests for the early detection/prevention of patients.

eliette.touati@pasteur.fr

Eliette Touati, J Infect Dis Ther 2018, Volume 6

DOI: 10.4172/2332-0877-C1-038